title: Rapid-response vaccines--does DNA offer a solution?
abstract: In responding to future influenza pandemics and other infectious agents, plasmid DNA overcomes many of the limitations of conventional vaccine production approaches.
authors.affiliation: Victorian Endowment for Science, Knowledge, and Innovation (VESKI), Department of Chemical Engineering, Monash University, Clayton, Melbourne, Australia, 3800. gareth.forde@eng.monash.edu.au
authors.forename: Gareth M
authors.initials: GM
authors.lastname: Forde
mesh_terms: D000818:Animals; D004247:DNA / Q000737:chemistry*; D004196:Disease Outbreaks / Q000517:prevention & control; D005818:Genetic Engineering; D014943:Global Health; D006801:Humans; D007252:Influenza Vaccines / Q000627:therapeutic use*; D007251:Influenza, Human / Q000517:prevention & control*; D051379:Mice; D010957:Plasmids / Q000378:metabolism; D013997:Time Factors; D014611:Vaccination; D014612:Vaccines / Q000737:chemistry*; D019444:Vaccines, DNA / Q000627:therapeutic use*; D014773:Virology / Q000379:methods / Q000639:trends*
chemical_list: D007252:Influenza Vaccines; D014612:Vaccines; D019444:Vaccines, DNA; D004247:DNA